Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Dec 13, 2022
Trial Information
Current as of January 21, 2025
Completed
Keywords
ClinConnect Summary
It will be randomized controlled trial. After approval of synopsis the research will be conducted at Bahawal Victoria hospital Bahawalpur and Sadiq abbasi hospital Bahawalpur. Written informed consent will be obtained. We take 60 patients (Epitool), Patients will be allocated randomly in two groups. Group A and group B. Group A will get conventional medical treatment and Group B will get both conventional medical treatment and pranayama breathing exercise. Both gender of age group 30 to 55, Patient with diagnosed COPD, Moderate to severe COPD with productive cough, SOB and no surgical proce...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both gender of age group 30 to 55
- • Patient with diagnosed COPD.
- • Moderate to severe COPD.
- • Patient with productive cough and SOB.
- • No surgical procedure perform.
- Exclusion Criteria:
- • Patient of lung surgery
- • Lung cancer patient
- • Patient above 70 years age.
- • Patient with open wound.
- • Patient with cardiovascular issues
Trial Officials
madiha younas, MS
Principal Investigator
riphah internationl university
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bahāwalpur, Punjab, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials